Prevalence, impairment and severity of 12-month DSM-IV major depressive episodes in Te Rau Hinengaro: New Zealand Mental Health Survey 2003/4

The Australian and New Zealand Journal of Psychiatry
Kate M ScottJ Elisabeth Wells

Abstract

To assess the prevalence, symptom severity, functional impairment and treatment of major depressive episodes in the New Zealand population, in light of recent criticism that depression is 'over-diagnosed', especially in community surveys. Nationally representative cross-sectional household survey of 12 992 adults (aged 16+): The New Zealand Mental Health Survey 2003/4. 12-month major depressive episode measured in face-to-face interviews with the Composite International Diagnostic Interview (CIDI 3.0). The 12-month prevalence of major depressive episode (MDE) was 6.6% for the total population, with decreasing prevalence with increasing age, and higher prevalence in females (8.1% versus 4.9% in males). Fewer than 10% of 12-month episodes were classified on a symptom severity rating scale as mild, and 69% of all episodes were accompanied by severe impairment in at least one domain of functioning. Only a third of those with severe impairment received treatment in the mental health sector, and half saw a general medical practitioner. These results offer little support for the suggestion that depression is over-diagnosed and over-treated, and that current diagnostic thresholds allow the inclusion of too many mild episodes in communi...Continue Reading

References

Jul 1, 1991·Journal of Occupational Medicine. : Official Publication of the Industrial Medical Association·D G HodgkinsW H Krebs
Mar 1, 1991·Social Psychiatry and Psychiatric Epidemiology·A MorgadoD Widlöcher
Jan 1, 1995·Health Affairs·P J Boyle, D Callahan
May 1, 1996·Psychological Medicine·A J RushM H Trivedi
Jan 1, 1997·International Journal of Psychiatry in Medicine·A C LeonD V Sheehan
Jun 19, 2003·JAMA : the Journal of the American Medical Association·Ronald C KesslerUNKNOWN National Comorbidity Survey Replication
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Aug 7, 2004·International Journal of Methods in Psychiatric Research·Ronald C Kessler, T Bedirhan Ustün
Jul 26, 2006·CNS Drugs·Jon Jureidini, Anne Tonkin
Sep 9, 2006·The Australian and New Zealand Journal of Psychiatry·J Elisabeth WellsUNKNOWN New Zealand Mental Health Survey Research Team
Sep 9, 2006·The Australian and New Zealand Journal of Psychiatry·J Elisabeth WellsUNKNOWN New Zealand Mental Health Survey Research Team
Sep 9, 2006·The Australian and New Zealand Journal of Psychiatry·Mark A Oakley BrowneUNKNOWN New Zealand Mental Health Survey Research Team
Sep 9, 2006·The Australian and New Zealand Journal of Psychiatry·Kate M ScottUNKNOWN New Zealand Mental Health Survey Research Team
Sep 9, 2006·The Australian and New Zealand Journal of Psychiatry·Kate M ScottUNKNOWN New Zealand Mental Health Survey Research Team
Sep 9, 2006·The Australian and New Zealand Journal of Psychiatry·Annette L BeautraisUNKNOWN New Zealand Mental Health Survey Research Team
Aug 19, 2007·BMJ : British Medical Journal·Gordon Parker
Sep 19, 2007·Brazilian Journal of Biology = Revista Brasleira De Biologia·A V Christianini, M Galetti
Mar 20, 2008·Annual Review of Public Health·Ronald C Kessler, Philip S Wang
Sep 9, 2008·The Australian and New Zealand Journal of Psychiatry·Gordon Parker
Nov 26, 2008·Journal of Psychosomatic Research·Elizabeth H B LinDavid Williams

❮ Previous
Next ❯

Citations

Aug 27, 2013·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Marilyn A Craven, Roger Bland
Jul 25, 2019·Psychotherapy and Psychosomatics·Brett ThombsIan Shrier

❮ Previous
Next ❯

Software Mentioned

SUDAAN

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.